Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve the unaudited financial ....

July 24, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Bandra-Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai - 400 051. Dalal Street, Mumbai – 400 001. Symbol: STAR Scrip Code: 532531 Dear Madam/ Sir, Sub: Intimation regarding Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Friday, July 31, 2026, to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2026, amongst other matters. Further, as per the provisions of Company’s Code of Conduct for Prohibition of Insider Trading, trading window for Designated Persons of the Company is closed from July 1, 2026 and shall open after 48 hours post declaration of financial results by the Company. The above information will also be available on website of the Company at www.strides.com. This is for your kind information and record purposes. Thanks & Regards, For Strides Pharma Science Limited, Manjula Ramamurthy Company Secretary & Compliance Officer ICSI Membership No.: A30515 Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India |Tel: +91 80 6784 0000 Regd. Off: ‘Cyber One’, Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924/3199 corpcomm@strides.com; www.strides.com